Brief: Nrx-Accounting For Features Of Substitute Warrants Issued May 24, 2021 In Merger Deal With Big Rock Partners Acquisition For Affected Periods Incorrect
Aug 12 (Reuters) - NRX Pharmaceuticals Inc NRXP.O :
* NRX-ACCOUNTING FOR FEATURES OF SUBSTITUTE WARRANTS ISSUED
MAY
24, 2021 IN MERGER DEAL WITH BIG ROCK PARTNERS ACQUISITION FOR
AFFECTED PERIODS INCORRECT
* NRX - ERROR HAD NO IMPACT ON CASH BALANCES OR OPERATING
CASH
FLOWS FOR THE AFFECTED PERIODS
* NRX - HAS DETERMINED THAT ERRORS WERE CAUSED BY A MATERIAL
WEAKNESS
Further company coverage: NRXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NRX Pharmaceuticals
See all newsBrief: NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024
U.S. RESEARCH ROUNDUP-Cintas Corp, Sprouts Farmers market, Voya Financial
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery
U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power
NRX Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview